Standardised case definitions for adverse events following immunisation

Comment

Ulrich Heininger. Lancet. 2013.

. 2013 Jun 29;381(9885):2250-1.

doi: 10.1016/S0140-6736(13)61477-4.

No abstract available

Comment in

Standardised case definitions for adverse events following immunisation - Authors' reply.
Vesikari T. Vesikari T. Lancet. 2013 Jun 29;381(9885):2251. doi: 10.1016/S0140-6736(13)61478-6. Lancet. 2013. PMID: 23809558 No abstract available.

Immunogenicity and safety of an investigational multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) administered concomitantly with routine infant and child vaccinations: results of two randomised trials.
Vesikari T, Esposito S, Prymula R, Ypma E, Kohl I, Toneatto D, Dull P, Kimura A; EU Meningococcal B Infant Vaccine Study group. Vesikari T, et al. Lancet. 2013 Mar 9;381(9869):825-35. doi: 10.1016/S0140-6736(12)61961-8. Lancet. 2013. PMID: 23324563 Clinical Trial.